KTCC2024
‘æ34‰ñ Kyoto T Cell Conference
“úŽžF2025”N6ŒŽ20“ú(‹à) ` 6ŒŽ21“ú(“y)
êŠF‹ž“s‘åŠwއ—–‰ïŠÙi§606-8315 ‹ž“sŽs¶‹ž‹æ‹g“c‹ß‰q’¬‹ž“s‘åŠwˆãŠw•”\“àj
W‰ï’·Fãp@•Û”NiŽ ‰êˆã‰È‘åŠw ¶‰»ŠwE•ªŽq¶•¨ŠwuÀ •ªŽq¶—‰»Šw•”–åj
----------------
‚Q‚O‚Q‚T”N‚UŒŽ‚Q‚O“úi‹à—j“új
13:00-13:10 ŠJ‰ï‚ÌŽ«
ƒZƒbƒVƒ‡ƒ“‚PF‹¹‘B×–E•ª‰»@i13:10-14:00j
À’·F‰œŽR ˆê¶i—‰»ŠwŒ¤‹†Š –Ɖu“]ŽÊ§ŒäŒ¤‹†ƒ`[ƒ€j
1-1. T×–E‚̉Šú”¶‚É‚¨‚¯‚éƒgƒ‰ƒ“ƒXƒtƒFƒŠƒ“Žó—e‘Ì1 (TfR1)‚Ì–ðŠ„
Š™ —Tˆêi“ŒŠC‘åEˆãE–Ɖuj
1-2. ˆÙ«Œ^ƒ|ƒŠƒR[ƒ€ŒQƒ^ƒ“ƒpƒNPCGF1, 3, 5‚Í«ˆË‘¶“I‚ÉT×–E•ª‰»‚ð§Œä‚·‚é
•½ì ^‹|i—‰È‘åE¶–½Œ¤E–ƉuƒAƒŒƒ‹ƒM[j
1-3. Two E-boxes in the Rag1-promoter is essential for the V(D)J recombination of Tcr and Igh genes.
“úûü —çŽqi‹ž“s‘åEˆã¶Œ¤EĶ–ƉuŠwj
1-4. Satb1‚ÍTCRƒVƒOƒiƒ‹‰ž“š‚Ì臒l‚ð§Œä‚·‚é
“à“¡ ‘ñ (“Œ–M‘åEˆãE–ƉuŠwj
1-5. FADS2Œ‡‘¹‚¨‚æ‚ÑPUFAŒ‡–R‚ª‹¹‘B‹@”\‚É—^‚¦‚é‰e‹¿‚̉ðÍ
Šâ’j sŒbi‚©‚¸‚³DNAŒ¤EƒIƒ~ƒbƒNƒXˆã‰ÈŠwj
ƒZƒbƒVƒ‡ƒ“‚QF‹¹‘Bã”ç×–E‚Æ”÷¬ŠÂ‹«@i14:00-14:50j
À’·FŽº —´”V‰îi“Œ‹ž—‰È‘åŠw ¶–½ˆã‰ÈŠwŒ¤‹†Š •ªŽq•a‘ÔŠw•”–åj
2-1. Wnt/ƒÀ-cateninƒVƒOƒiƒ‹‚ª‹¹‘Bã”ç×–E‚Ì•ª‰»‚ƈێ‚ɉʂ½‚·–ðŠ„
“¡X ‚³‚ä”üi“¿“‡‘åEæ’[y‘fŒ¤E–ƉuŒn”¶Šwj
2-2. —cŽáŠúASCL1”Œ»×–E‚ÍAIRE”Œ»×–E‚ð’·Šú‚ɂ킽‚苟‹‹‚·‚é
HŽR LŽqi—Œ¤EIMSE–ƉuPí«j
2-3. ‹óŠÔƒgƒ‰ƒ“ƒXƒNƒŠƒvƒg[ƒ€‚ƃVƒ“ƒOƒ‹ƒZƒ‹RNA-seq‚É‚æ‚é˜V‰»‹¹‘BŠÂ‹«‚̉ðÍ
•À–Ø ‰À”Ti—Œ¤EIMSE–ƉuPí«j
2-4. ‹¹‘B‚Ì‹}«‘Þk‚É‚¨‚¯‚é”÷¬ŠÂ‹«‚ÌŠh—
‹k ‘쌩i“Œ‘åEˆãE–ƉuA—‰È‘åŠwE¶–½Œ¤j
2-5. Phospholipase C-related but catalytically inactive proteins regulate gut-associated lymphoid tissue development
àV Vˆê˜Yi‹ãB‘åE¶ˆãŒ¤E”S–Œ–hŒäŠwj
ƒZƒbƒVƒ‡ƒ“‚RFT×–E‚Ì‹@”\’²ß@i15:20-16:00j
À’·FˆÉ“¡ b—YiŽ ‰êˆã‰È‘åŠw@¶‰»ŠwE•ªŽq¶•¨ŠwuÀ@•ªŽq¶—‰»Šw•”–åj
3-1. CD69‚̓AƒSƒjƒXƒgTCRƒVƒOƒiƒ‹‚ð§Œä‚·‚é
‰““¡ «‘åiç—t‘åEˆãEŽÀŒ±–ƉuŠwj
3-2. ‹óŠÔBioID–@‚É‚æ‚éTCRM†“`’BŒn‚Ì–Ô—…“I‰ðÍ
Œ´“c ~Žii—Œ¤EIMSE–Ɖu“]ŽÊ§Œäj
3-3. T×–E‚É‚¨‚¯‚é’ᕪŽq—ÊGƒ^ƒ“ƒpƒNŽ¿Arf‚Ì–ðŠ„‰ð–¾‚ÉŒü‚¯‚½ArfŒo˜H‘jŠQ܂̒Tõ
Z‹g@–ƒŽÀiŠÖ¼ˆã‘åE¶–½ˆãŠwE¶‘Ìî•ñj
3-4. uŽ‰Ž¿‘ãŽÓ-Ž©ŒÈŠjŽ_v‚É‚æ‚éSTING‚ÌV‹K–Ɖu§Œä‹@\
›–ì •q¶i‚©‚¸‚³DNAŒ¤EƒIƒ~ƒbƒNƒXˆã‰ÈŠwj
ƒZƒbƒVƒ‡ƒ“‚SFƒGƒtƒFƒNƒ^[/ƒƒ‚ƒŠ[T×–E@i16:00-16:40j
À’·F‹ß“¡ Œ’‘¾iŽ ‰êˆã‰È‘åŠw@¶‰»ŠwE•ªŽq¶•¨ŠwuÀ@•ªŽq¶—‰»Šw•”–åj
4-1. Bach2‚Í Utx‚Æ‹¦’²‚µ‚Äì—p‚µAƒGƒtƒFƒNƒ^[ CD8 T ×–E‚ÌI––•ª‰»‚ð§Œä‚·‚é
ŒKŒ´ ½iˆ¤•Q‘åEˆãE–ƉuŠwj
4-2. ‹L‰¯ƒwƒ‹ƒp[T×–EŒ`¬‚̧Œä‹@\
‘å–Ø ‚±‚±‚ëi’¹Žæ‘åEˆãE–ƉuŠwj
4-3. ’·ŠúˆÛŽ”\‚ð—L‚·‚é”x”S–Œstem—lƒŒƒWƒfƒ“ƒgƒƒ‚ƒŠ[CD8+T×–E‚Ì“¯’è‚Æ‚»‚Ì«ó‰ðÍ
–k”¨ F—Si—Œ¤EIMSE–Ɖu‹L‰¯j
4-4. ¶‘Ì“àƒrƒ^ƒ~ƒ“C‚ªCD8+ T×–E‚É‹y‚Ú‚·‰e‹¿‚̉ð–¾
‹ß“¡ Œ’‘¾iŽ ‰êˆã‰È‘åE¶‰»ŠwE•ªŽq¶•¨Šwj
ƒZƒbƒVƒ‡ƒ“‚TFŽ©‘RƒŠƒ“ƒp‹…@i17:10-17:50j
À’·FŒÃ‰ê —@ i‘åã‘åŠw‘åŠw‰@ ˆãŠwŒnŒ¤‹†‰È ¶‘Ì–hŒäŠw‹³Žºj
5-1. ’×ᇫ‘å’°‰Š‚É‚¨‚¯‚é’×ᇕ”“ÁˆÙ“IIL-33+üˆÛ‰è×–E‚Ì‹@”\‰ðÍ
•Ÿ“ˆ —DŠói‘åã‘åEˆãE¶‘Ì–hŒäŠwj
5-2. ILC3-intrinsic Runx/CbfƒÀ is essential for ILF formation.
¬—Ñ —剛i‹ãB‘åE¶ˆãŒ¤E”S–Œ–hŒäŠwj
5-3. 1Œ^Ž©‘RƒŠƒ“ƒp‹…‚É‚æ‚é”畆ƒ^[ƒ“ƒI[ƒo[’²ß‹@\
¬—Ñ “N˜Yi—Œ¤EIMSEŽ©‘R–ƉuƒVƒXƒeƒ€j
5-4. uILC3‚ª‹ì“®‚·‚é–å–¬ˆË‘¶“I‚ÈŽ‰Ž¿—A‘—‹@\v‚ð‚æ‚èˆê”Ê“I‚ɉðŽß‚·‚é
ŽOàV@‘ñ”ni—Œ¤EIMSE–Ɖu×–EƒVƒXƒeƒ€j
17:50-18:30 ƒ|ƒXƒ^[ƒZƒbƒVƒ‡ƒ“‡T
18:30-20:30 ˆÓŒ©ŒðŠ·‰ï
‚Q‚O‚Q‚T”N‚UŒŽ‚Q‚P“úi“y—j“új
ƒZƒbƒVƒ‡ƒ“‚UF§Œä«T×–E‚ƖƉuа—e@i9:30-10:20j
À’·F—¢‰ª ‘åŽ÷iŽ ‰êˆã‰È‘åŠw ¶–½‰ÈŠwuÀ ¶•¨Šwj
6-1. Treg-mediated immune homeostasis requires loop-extrusion via cohesin complex
“¡Œ´ Œ’‘¾˜Yi‹ž“s‘åEˆã¶Œ¤EĶ–ƉuŠwj
6-2. ŒoŒû–Ɖuа—e‚É‚æ‚é”畆’x‰„Œ^‰ß•q”½‰ž‚Ì—}§‹@\‚̉ð–¾
Ô–Ø —L¹i‹ž“s‘åEˆãE”畆‰ÈŠwj
6-3. TIGIT”Œ»‚ð‹L‰¯‚·‚邱‚Æ‚ÅAiTreg×–E‚Í—}§‹@”\‚ð“`³‚·‚é
ªŠÝ ®Žqi‡“V“°‘åEƒAƒgƒs[޾гŒ¤‹†ƒZƒ“ƒ^[j
6-4. iTregˆÀ’艻‚ð’S‚¤TCR-mTORC1-TETˆË‘¶“IFoxp3ƒGƒsƒQƒmƒ€§Œä
’†“‡ Œ[i“Œ‹ž‘åE–òE–ƉuE”÷¶•¨Šwj
6-5. §Œä«T×–E‚̖Ɖu§Œä‹@”\‚É‚¨‚¯‚éRŒ´“ÁˆÙ«‚Ì–ðŠ„
’ÃŒ´ –G—¢i“Œ‹ž‘åE–òE–ƉuE”÷¶•¨Šwj
ƒZƒbƒVƒ‡ƒ“‚VF–Ɖu޾г@i10:20-11:10j
À’·FŒKŒ´ ½iˆ¤•Q‘åŠw‘åŠw‰@ ˆãŠwŒnŒ¤‹†‰È Š´õ–hŒäŠwuÀj
7-1. ƒvƒƒeƒA[ƒ[ƒAƒŒƒ‹ƒQƒ“‹C“¹‰ŠÇƒ‚ƒfƒ‹‚É‚¨‚¯‚郌ƒWƒfƒ“ƒgƒƒ‚ƒŠ[Th2×–E‚̉ðÍ
㞊 ´Žki‡“V“°‘åEƒAƒgƒs[޾гŒ¤‹†ƒZƒ“ƒ^[j
7-2. ’ᕪŽq‰»‡•¨SH-2251‚ÍPARƒ¿‚ÆŒ‹‡‚µAIL-5ŽY¶Th2×–E•ª‰»‚Æ2Œ^ƒAƒŒƒ‹ƒM[«‹C“¹‰ŠÇ‚ð—}§‚·‚é
–쑺 r‰îiˆ¤•Q‘åEˆãEŠ´õ–hŒäŠwj
7-3. D’†‹…‚ÍIL-23 p19ƒ‚ƒmƒ}[‚ð‰î‚µ‚Ä17Œ^–Ɖu‰ž“š‚ð—}§‚·‚é
¬Œ´ ”T–çi‹ž“s‘åEˆã¶Œ¤E“‡¶‘̃vƒƒZƒXj
7-4. T×–E‚̃Zƒ‹ƒt‚ƃlƒIƒZƒ‹ƒtޝ•ʂɂæ‚鎩ŒÈ–Ɖu޾г‚̔Nj@\
X r•ãi‘åã‘åE”÷Œ¤E–Ɖu‰»Šwj
7-5. MHCƒNƒ‰ƒXII•ªŽq‚ÍCD4 T×–E‚ÆLAG-3ˆË‘¶“I‹@\‚É‚æ‚è‘å’° CD8 T×–E‚ÌŠˆ«‰»‚ð§Œä‚·‚é
ç‹e ’q–çi“Œ‹ž‘åE–òE–ƉuE”÷¶•¨Šwj
ƒZƒbƒVƒ‡ƒ“‚WFƒqƒg–Ɖu‚Æ‚ª‚ñ–Ɖu@i14:10-15:00j
À’·F“ß{ —ºiç—t‘åŠw ‘åŠw‰@ˆãŠwŒ¤‹†‰@ ŽÀŒ±–ƉuŠwj
8-1. ƒqƒgŠÌCD4 T×–E‚Ì‘½—l«‚ÆCMVŠÄŽ‹‹@\‚Ö‚ÌŠÖ—^
X“c Œ³i‹ž“s‘åEˆãE–Ɖu×–E¶•¨Šwj
8-2. Hepatic macrophage subsets in the human liver: Heterogeneity, Effect of aging, and Alterations in autoimmune diseases
Shuhe Mai‹ž“s‘åEˆãE–Ɖu×–E¶•¨Šwj
8-3. ŽîᇖƉu‚É‚¨‚¯‚éMemory-phenotype CD4 T×–E‚Ì–ðŠ„
‰Í•” „Žji“Œ–k‘åEˆãE–ƉuŠwj
8-4. CAR•ªŽq‚ÌŽ‘±“IƒŠƒ“Ž_‰»‚É‚æ‚éCAR-T×–E”敾‚ðŽ•ž‚·‚éCAR‚ÌŠJ”
Žá¼ ‰pi“Œ‹žˆã‰È‘åE–ƉuŠw•ª–ìj
8-5. The role of thymic pDC in tumor immune tolerance
Wang, Yangsongiç—t‘åE ˆãEŽÀŒ±–ƉuŠwj
ƒZƒbƒVƒ‡ƒ“‚XF–Ɖu—Ö@@i15:00-15:40j
À’·F‰i–ì ½Ž¡i‹ž“s‘åŠw Ķˆã‰ÈŠwŒ¤‹†Š Ķ–ƉuŠw•ª–ìj
9-1. ƒqƒgT/NK‘O‹ì×–E‚Ì“¯’肨‚æ‚Ñ•ª‰»§Œä‹@\‚̉ð–¾
–ìŠÔ ‚©‚è‚ñi—‰È‘åE¶–½Œ¤E–ƉuƒAƒŒƒ‹ƒM[j
9-2. NK×–E‚É‚æ‚éˆÚA•Ћ‘┽‰ž‚ðNK×–E—}§«ƒŒƒZƒvƒ^[‚ɑ΂·‚é–ŒŒ^R‘Ì‚ð—p‚¢‚Ä—}§‚·‚é•û–@‚ÌŠJ”
”ÂŒ´ ‘½—Ei‹ž“s‘åEˆã¶Œ¤EĶ–ƉuŠwj
9-3. ƒhƒi[—R—ˆiPS×–EˆÚA‚ª—U“±‚·‚éƒhƒi[RŒ´“ÁˆÙ“I–Ɖuа—e‚Ì‹@˜‰ðÍ
Š™’J ’q‹Ii–kŠC“¹‘åEˆâ§Œ¤E–Ɖu¶•¨j
9-4. ‘¼‰ÆÄ¶T×–E‚ð—p‚¢‚½ƒEƒCƒ‹ƒXŠ´õÇŽ¡—×p×–E»Ü‚ÌŠJ”
ã–x ~“ñi‹ž“s‘åEˆã¶Œ¤EĶ–ƉuŠwj
15:40-15:45 •‰ï‚ÌŽ«
----------------
-->
Go back to the KTCC top
page
Last updated; Jun 13, 2025
@